Prix Galien Russia, November 18, 2016 /PRNewswire/ --
Laureates to be recognized by Research and Academic Leaders at Awards Ceremony on December 1st in Moscow
The Prix Galien Russia Committee (or Jury) comprises 15 renowned leaders in biomedical research and academia and is responsible for evaluating nominees based on scientific files. Laureates will be honored at the Prix Galien Russia Awards Ceremony at Volkhonka Mansion, on the 1st of December 2016
The Prix Galien Russia Committee designates a laureate in 6 different categories by evaluating scientific applications files submitted by the candidates based solely on two questions:
Frederic Boucheseiche, General Secretary of Prix Galien Russia, reiterated the uniqueness and importance of Prix Galien by emphasizing the fact that the Jury's decision is based only on scientific and medical criteria, that marketing and commercial considerations never enter into the Jury's decision, and by restating that pharmaceutical companies cannot sponsor the event.
"Organizing an awards ceremony under such strict principles is extremely challenging, but this is the condition that guarantees the impartiality of the jury's decision. Prix Galien Russia uses the same strict criteria as in all other countries where the award is held, making its legitimacy indisputable." Frederic Boucheseiche.
Nominees for the Prix Galien Russia 2016 Awards are:
Best Orphan Drug (Nominees)
Opsumit® - Actelion Pharmaceuticals RUS, Ltd
Blinatumobab - Amgen
Best Pharmaceutical Agent (Nominees)
Forxiga - AstraZeneca
Lynparza - AstraZeneca
Viekira Pak - Abbvie
Otezla - Celgene
Imbruvica - Janssen, Pharmaceutical companies of Johnson & Johnson
FORSTEO® - Eli Lilly
Trulicity - Eli Lilly
Best Biotechnology Product (Nominees)
Evolocumab - Amgen
YERVOY® - Bristol-Myers Squibb
Sovriad - Janssen, Pharmaceutical companies of Johnson & Johnson
Zelboraf - Roche / R-Pharm
Beyodym - Roche / R-Pharm
Best Medical Technology (Nominees)
Absorb - Abbott
OneTouch Verio® IQ - Johnson & Johnson
Best Research in Russia (Nominees)
Development of a new generation of Antivirals of the family of azoloazines - Institute of Organic Synthesis
Nanoencapsulated colistin - BIND (RUS) LLC
Mobilan - Panacela Labs
OncoFinder platform for personalized selection of drugs in oncology - First Oncology Research and Advisory Center
Best Russia Product (Nominees)
ImmunoQuantex "Femoflor®"+ «ImmunoQuantex" - DNA-Technology LLC/ Federal State Budget Institution "Research Center for Obstetrics, Gynecology and Perinatology" Ministry of Healthcare of the RF
Seroguard - JSC "Pharmasyntez"
Triazavirin - MEDSYNTHEZ
Prix Galien Jury
Prof. Sergey Olegovich Bachurin
Prof. Sergey Anatolievich Boytsov
Prof. Vladimir Trofimovich Ivashkin
Prof. Eugeny Lvovich Nasonov
Prof. Rem Viktorovich Petrov ?????????
Prof. Dmitry Yurievich Pushkar
Prof. Gennady Tikhonovich Sukhikh
Prof. Evgeny Davidovich Sverdlov
Prof. Michael Veniaminovich Ugrumov
Prof. Valery Mikhailovich Zaiko
Prof. Amiran Shotaevich Revishvili
Prof. Khristo Periklovich Takhchidi
Prof. Altksey Izrailevich Mazus
Prof. Igor Evgenievich Khatkov
Prof. Igor Evgenievich Tyurin
General Secretary Frederic Boucheseiche
About Prix Galien Russia:
Prix Galien Russia was inaugurated in Moscow in 2013 under the auspice of an exceptional awards committee composed of eminent specialists involved in the sphere of Russian and international pharmaceutical research.
A Prix Galien Award is considered the biomedical industry's highest accolade and recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines.
Around the world, Prix Galien rewards outstanding achievements in improving the global human condition through the development of innovative therapies. Created in France 40 years ago, Prix Galien has selection committees in 16 countries around the world.
More information on: http://prixgalienrussia.com
SOURCE Prix Galien Russia
Subscribe to our Free Newsletters!